MRTX logo

Mirati Therapeutics (MRTX) Current Assets

Annual Current Assets

$1.11 B
-$399.02 M-26.46%

31 December 2022

MRTX Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Assets

$1.04 B
+$217.16 M+26.52%

30 September 2023

MRTX Quarterly Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MRTX Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--
3 y3 years-26.5%-31.3%
5 y5 years+161.3%+144.1%

MRTX Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years
5 y5 years
alltimeall time-26.5%-31.3%

Mirati Therapeutics Current Assets History

DateAnnualQuarterly
Sept 2023
-
$1.04 B(+26.5%)
June 2023
-
$818.92 M(-12.8%)
Mar 2023
-
$939.35 M(-15.3%)
Dec 2022
$93.69 M(+16.0%)
$1.11 B(-9.5%)
Sept 2022
-
$1.23 B(+1.9%)
June 2022
-
$1.20 B(-10.4%)
Mar 2022
-
$1.34 B(-10.9%)
Dec 2021
$80.77 M(+11.4%)
$1.51 B(+28.7%)
Sept 2021
-
$1.17 B(-8.3%)
June 2021
-
$1.28 B(-1.9%)
Mar 2021
-
$1.30 B(-7.1%)
Dec 2020
$72.48 M(+830.1%)
$1.40 B(+135.8%)
Sept 2020
-
$595.39 M(-9.0%)
June 2020
-
$654.04 M(-7.2%)
Mar 2020
-
$704.82 M(+66.1%)
Dec 2019
$7.79 M(+334.4%)
$424.41 M(-8.7%)
Sept 2019
-
$464.65 M(-6.3%)
June 2019
-
$495.71 M(+61.8%)
Mar 2019
-
$306.38 M(+35.2%)
Dec 2018
$1.79 M(+20.6%)
$226.66 M(-7.9%)
Sept 2018
-
$246.10 M(-6.6%)
June 2018
-
$263.60 M(+72.2%)
Mar 2018
-
$153.07 M(-1.7%)
Dec 2017
$1.49 M(-61.8%)
$155.76 M(+96.2%)
Sept 2017
-
$79.40 M(-14.0%)
June 2017
-
$92.28 M(-14.5%)
Mar 2017
-
$107.92 M(+81.2%)
Dec 2016
$3.89 M(+48.7%)
$59.55 M(-21.1%)
Sept 2016
-
$75.49 M(-18.9%)
June 2016
-
$93.04 M(-15.3%)
Mar 2016
-
$109.90 M(-12.4%)
Dec 2015
$2.62 M(+218.1%)
$125.40 M(-11.1%)
Sept 2015
-
$141.04 M(+131.6%)
June 2015
-
$60.89 M(-14.5%)
Mar 2015
-
$71.19 M(+118.0%)
Dec 2014
$822.00 K
$32.66 M(-19.1%)
Sept 2014
-
$40.34 M(-17.9%)
June 2014
-
$49.16 M(-12.3%)
DateAnnualQuarterly
Mar 2014
-
$56.04 M(-12.7%)
Dec 2013
$322.00 K(-31.8%)
$64.22 M(+277.3%)
Sept 2013
-
$17.02 M(-24.1%)
June 2013
-
$22.44 M(-28.8%)
Mar 2013
-
$31.52 M(-19.9%)
Dec 2012
$472.00 K(-23.9%)
$39.33 M(+99.3%)
Sept 2012
-
$19.73 M(-13.5%)
June 2012
-
$22.82 M(-15.6%)
Mar 2012
-
$27.05 M(-10.9%)
Dec 2011
$620.00 K(-48.3%)
$30.34 M(-7.0%)
Sept 2011
-
$32.63 M(-15.4%)
June 2011
-
$38.59 M(+385.0%)
Mar 2011
-
$7.96 M(-18.1%)
Dec 2010
$1.20 M(-42.2%)
$9.71 M(-21.5%)
Sept 2010
-
$12.37 M(-23.7%)
June 2010
-
$16.22 M(+13.6%)
Mar 2010
-
$14.27 M(-24.6%)
Dec 2009
$2.07 M(+2.8%)
$18.94 M(-13.8%)
Sept 2009
-
$21.96 M(-18.6%)
June 2009
-
$26.99 M(-13.1%)
Mar 2009
-
$31.05 M(-17.6%)
Dec 2008
$2.02 M(-63.1%)
$37.69 M(-19.0%)
Sept 2008
-
$46.56 M(-14.6%)
June 2008
-
$54.55 M(-11.2%)
Mar 2008
-
$61.44 M(-10.2%)
Dec 2007
$5.47 M(+10.7%)
$68.38 M(-6.6%)
Sept 2007
-
$73.18 M(+0.6%)
June 2007
-
$72.76 M(-0.3%)
Mar 2007
-
$73.01 M(+20.0%)
Dec 2006
$4.95 M(-7.4%)
$60.82 M(-6.4%)
Sept 2006
-
$65.01 M(+3.5%)
June 2006
-
$62.78 M(+40.4%)
Mar 2006
-
$44.71 M(+80.4%)
Dec 2005
$5.34 M(+14.7%)
$24.78 M(-11.9%)
Sept 2005
-
$28.13 M(-4.9%)
June 2005
-
$29.57 M(-12.1%)
Mar 2005
-
$33.65 M
Dec 2004
$4.66 M(-0.9%)
-
Dec 2003
$4.70 M
-

FAQ

  • What is Mirati Therapeutics annual total current assets?
  • What is the all time high annual current assets for Mirati Therapeutics?
  • What is Mirati Therapeutics quarterly total current assets?
  • What is the all time high quarterly current assets for Mirati Therapeutics?

What is Mirati Therapeutics annual total current assets?

The current annual current assets of MRTX is $1.11 B

What is the all time high annual current assets for Mirati Therapeutics?

Mirati Therapeutics all-time high annual total current assets is $1.51 B

What is Mirati Therapeutics quarterly total current assets?

The current quarterly current assets of MRTX is $1.04 B

What is the all time high quarterly current assets for Mirati Therapeutics?

Mirati Therapeutics all-time high quarterly total current assets is $1.51 B